Placeholder Picture

Stemedica Cell Technologies Announces Completion of Enrollment in Phase I/IIa Clinical Trial for Ischemic Stroke - NEW!
Stemedica Establishes Stem Cell Commercial Manufacturing Facility - NEW!
FDA Approves STEMEDICA Phase II Clinical Trial for Acute Myocardial Iinfarction with Ischemia Tolerant Mesenchymal Stem Cells
Indonesia’s BPOM Grants IND Approval for SCI to Conduct a Phase II Clinical Trial using Stemedica’s Mesenchymal Stem Cells to Treat Acute Myocardial Infarction
FDA Approves STEMEDICA IND Application for STEMEDYNE™-MSC in Cutaneous Photoaging
STEMEDICA Iinternational Receives Licenses From SWISSMEDIC For Import and Export of Its STEMEDYNE™ Stem Cell Line
STEMEDICA Stem Cells Approved For Clinical Trials in Mexico For Chronic Heart Failure
STEMEDICA International and Academic Partner Awarded Swiss Alzheimer’s and Stem Cell Research Grant
STEMEDICA Completes Pre-IND Meeting With The FDA For Ischemic Tolerant Neural Stem Cells (itNSC)
STEMEDICA Neural Stem Cells Successful in Preclinical Study of Spinal Cord Injury
STEMEDICA Completed Enrollment In First Cohort of Patients With Ischemic Stroke Utilizing Allogeneic Mesenchymal Stem Cells
Stemedica International and EPFL Awarded Swiss Government Grant for Diabetes and Stem Cell Research
Stemedica International Announces Pre-clinical Data of its Alzheimer’s Study

Stem Cell Save The Children, LLC © 2006 All Rights Reserved
Design: TTMAR Consulting